NKTR
Nektar Therapeutics
NASDAQ: NKTR · HEALTHCARE · BIOTECHNOLOGY
$38.55
+1.53% today
Updated 2026-10-28
Market cap
$1.22B
P/E ratio
—
P/S ratio
22.38x
EPS (TTM)
$-18.96
Dividend yield
—
52W range
$33 – $109
Volume
1.2M
Nektar Therapeutics (NKTR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$38.55
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -287.80%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.